🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Drug Discontinuation

Enhancing Hypnotic Medication Discontinuation in Primary Care NCT06435520Phase 41 site📍 Denver National Jewish Health · Tests: Digital Cognitive Behavioral Therapy, Structured Medication Tapering Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD NCT05192122Phase 11 site📍 Chicago University of Illinois at Chicago · Tests: Discontinue maintenance therapy SOC PRImary Care Strategies for Weight Management (PRISM) Study NCT07288294NA1 site📍 Chicago Rush University Medical Center · Tests: PRISM Program Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation NCT07387796NA1 site📍 Dallas The University of Texas at Dallas · Tests: Discontinuation and Reinitiation of Tirzepatide Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors NCT07802678Phase 44 sites📍 Nijmegen📍 Tilburg📍 Amsterdam Sint Maartenskliniek · Tests: Strategy to attempt discontinuation of MTX or LEF (and restart when necessary), Continuation of MTX or LEF Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD NCT06511882Phase 21 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Azacitidine, Decitabine, Venetoclax CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD NCT05609916NA1 site📍 Houston Baylor College of Medicine · Tests: Cognitive Behavioral Therapy Outcomes After Planned Discontinuation of AntiSeizure Medication NCT07750496Phase 41 site📍 Ann Arbor University of Michigan · Tests: Discontinue antiseizure medications Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial NCT05652673NA1 site📍 Rotterdam Erasmus Medical Center · Tests: nivolumab Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2 NCT06742931NA18 sites📍 Ansan📍 Daegu📍 Gangneung Samsung Medical Center · Tests: Discontinuation of antiplatelet agent group, Continuation of antiplatelet agent group The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study NCT06377852Phase 388 sites📍 Chandler📍 Gilbert📍 Glendale American Society of Clinical Oncology · Tests: Palbociclib 125mg, Ribociclib 600mg, Ribociclib, Palbociclib The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER NCT07502820Phase 34 sites📍 Borås📍 Skövde📍 Stockholm Karolinska Institutet · Tests: Individual dose of tamoxifen, Standard adjuvant therapy of tamoxifen
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy